Diana Handke

520 total citations
17 papers, 438 citations indexed

About

Diana Handke is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Diana Handke has authored 17 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Diana Handke's work include Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (4 papers). Diana Handke is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (4 papers). Diana Handke collaborates with scholars based in Germany, Austria and Switzerland. Diana Handke's co-authors include Barbara Seliger, Anja Müeller, Juergen Bukur, Wolfgang Altermann, Chiara Massa, Michael Friedrich, Bernd Wullich, Simon Jasinski‐Bergner, Robert Stoehr and Ferdinand Hofstaedter and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Diana Handke

17 papers receiving 436 citations

Peers

Diana Handke

IMMUN

ONCOL

PRM

Tjitske Duiveman‐de Boer Netherlands

Angela D. Pardee United States

Apostolos C Ziogas Greece

Candice Perry United States

Josephine Walton United Kingdom

Hedda H. van Ravenswaay Claasen Netherlands

Alejandra Gutiérrez‐González Spain

Dov Zippel Israel

Susanne Sprung Austria

Amber Beyer United States

Tjitske Duiveman‐de Boer Netherlands

Diana Handke

365 ×1.3

IMMUN

292 ×1.4

ONCOL

176 ×1.3

41 ×0.7

19 ×0.4

PRM

Citations per year, relative to Diana Handke Diana Handke (= 1×) peers Tjitske Duiveman‐de Boer

Countries citing papers authored by Diana Handke

Since Specialization

Citations

This map shows the geographic impact of Diana Handke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Handke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Handke more than expected).

Fields of papers citing papers by Diana Handke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Handke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Handke. The network helps show where Diana Handke may publish in the future.

Co-authorship network of co-authors of Diana Handke

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Handke. A scholar is included among the top collaborators of Diana Handke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Handke. Diana Handke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Handke, Diana, et al.. (2024). Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome. Current Issues in Molecular Biology. 46(4). 3379–3393. 3 indexed citations

Vaxevanis, Christoforos, Michael Friedrich, Sandy Tretbar, et al.. (2022). Identification and characterization of novel CD274 (PD‐L1) regulating microRNAs and their functional relevance in melanoma. Clinical and Translational Medicine. 12(7). e934–e934. 6 indexed citations

Greither, Thomas, et al.. (2021). Lower Spermatozoal PIWI-LIKE 1 and 2 Transcript Levels Are Significantly Associated with Higher Fertilization Rates in IVF. International Journal of Molecular Sciences. 22(21). 11320–11320. 5 indexed citations

Meyer, Stefanie, Diana Handke, Anja Müeller, et al.. (2021). Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma. Cancers. 13(15). 3907–3907. 7 indexed citations

Massa, Chiara, Michael Friedrich, Diana Handke, et al.. (2020). Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients. OncoImmunology. 9(1). 1774323–1774323. 29 indexed citations

Massa, Chiara, Diana Handke, Anja Müeller, et al.. (2020). Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma. Journal of Clinical Medicine. 9(9). 2690–2690. 22 indexed citations

Friedrich, Michael, Simon Jasinski‐Bergner, Chiara Massa, et al.. (2019). Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunology Immunotherapy. 68(10). 1689–1700. 62 indexed citations

Kielstein, Heike, Peter Koelblinger, Reinhard Dummer, et al.. (2019). Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma. Oncotarget. 10(60). 6509–6525. 6 indexed citations

Meyer, Stefanie, Diana Handke, Anja Müeller, et al.. (2015). Role of signal transduction and microRNAs on the immunogenicity of melanoma cells. Journal of Translational Medicine. 13(S1). 8 indexed citations

10.

Bormann, Felix, Christine Sers, Barbara Seliger, et al.. (2011). Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns. Molecular Genetics and Genomics. 286(3-4). 279–91. 5 indexed citations

11.

Mimura, Kousaku, Takashi Ando, Isabel Poschke, et al.. (2010). T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2. International Journal of Cancer. 128(2). 390–401. 48 indexed citations

12.

Bukur, Juergen, F Herrmann, Diana Handke, Christian V. Recktenwald, & Barbara Seliger. (2010). Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression. Journal of Biological Chemistry. 285(40). 30419–30426. 33 indexed citations

13.

Seliger, Barbara, et al.. (2010). Novel role of a tyrosine kinase inhibitor by reversion of immune suppression in renal cell carcinoma.. Journal of Clinical Oncology. 28(15_suppl). e15122–e15122. 1 indexed citations

14.

Seliger, Barbara, Robert Stoehr, Diana Handke, et al.. (2009). Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunology Immunotherapy. 59(4). 529–540. 79 indexed citations

15.

Seliger, Barbara, et al.. (2009). Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma. Journal of Translational Medicine. 7(1). 90–90. 27 indexed citations

16.

Schlaf, Gerald, et al.. (2008). Expression and regulation of non‐classical HLA‐G in renal cell carcinoma. Tissue Antigens. 72(2). 137–148. 45 indexed citations

17.

Norell, Håkan, Mattias Carlsten, Karl‐Johan Malmberg, et al.. (2006). Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity. Cancer Research. 66(12). 6387–6394. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact